ANDRES MANUEL R
CERVANTES RUIPEREZ
CATEDRÁTICO/A DE UNIVERSIDAD
Beckman Research Institute
City of Hope, Estados UnidosPublicacions en col·laboració amb investigadors/es de Beckman Research Institute (4)
2024
-
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial
Nature Medicine, Vol. 30, Núm. 1, pp. 271-278
2023
-
Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study
Clinical Colorectal Cancer, Vol. 22, Núm. 1, pp. 100-110
-
Safety and clinical activity of atezolizumab plus erlotinib in patients with non-small-cell lung cancer
ESMO Open, Vol. 8, Núm. 2
2019
-
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
The Lancet Oncology, Vol. 20, Núm. 6, pp. 849-861